Physician profile
Abdul Malik
NPI 1578664942
$274.61
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $27.25 · 2021: $16.95 · 2022: $33.22 · 2024: $15.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $124.88 | 2019 | |
| Lilly USA, LLC | $38.19 | 2019-2022 | |
| Pfizer INC. | $28.77 | 2019 | |
| Amarin Pharma, INC. | $16.95 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.45 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.43 | 2024 | |
| Alnylam Pharmaceuticals INC. | $11.93 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.80 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.21 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdul Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.